COVID-19 vaccine development from the perspective of cancer patients

Currently, many companies around the world are actively developing COVID-19 vaccines. Fourteen vaccines with reliable safety and effectiveness are being successfully distributed to the public. However, there is no specific clinical trial data of the vaccines currently on the market on cancer patient...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Yang, Ding, Yi, Cao, Bo, Huang, Yi, Wang, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Mini-Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437497/
https://www.ncbi.nlm.nih.gov/pubmed/34170788
http://dx.doi.org/10.1080/21645515.2021.1943988
_version_ 1783752175449538560
author He, Yang
Ding, Yi
Cao, Bo
Huang, Yi
Wang, Xiao
author_facet He, Yang
Ding, Yi
Cao, Bo
Huang, Yi
Wang, Xiao
author_sort He, Yang
collection PubMed
description Currently, many companies around the world are actively developing COVID-19 vaccines. Fourteen vaccines with reliable safety and effectiveness are being successfully distributed to the public. However, there is no specific clinical trial data of the vaccines currently on the market on cancer patients at various stages, so the safety and effectiveness on cancer patients is unknown. This mini-review aims to discuss the impact of COVID-19 on cancer patients, and the urgent need of COVID-19 vaccines for cancer patients. In this review, we described the current status of the COVID-19 vaccine usages in cancer patients, as well as discussed potential problems in the use of vaccine. In addition, we included an original survey of the acceptance of the COVID-19 vaccines in 209 cancer patients and their family members. COVID-19 vaccine can provide cancer patients with social and medical benefits; therefore, clinical trials of vaccines on cancer patients are in great need.
format Online
Article
Text
id pubmed-8437497
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-84374972021-09-14 COVID-19 vaccine development from the perspective of cancer patients He, Yang Ding, Yi Cao, Bo Huang, Yi Wang, Xiao Hum Vaccin Immunother Mini-Review Currently, many companies around the world are actively developing COVID-19 vaccines. Fourteen vaccines with reliable safety and effectiveness are being successfully distributed to the public. However, there is no specific clinical trial data of the vaccines currently on the market on cancer patients at various stages, so the safety and effectiveness on cancer patients is unknown. This mini-review aims to discuss the impact of COVID-19 on cancer patients, and the urgent need of COVID-19 vaccines for cancer patients. In this review, we described the current status of the COVID-19 vaccine usages in cancer patients, as well as discussed potential problems in the use of vaccine. In addition, we included an original survey of the acceptance of the COVID-19 vaccines in 209 cancer patients and their family members. COVID-19 vaccine can provide cancer patients with social and medical benefits; therefore, clinical trials of vaccines on cancer patients are in great need. Taylor & Francis 2021-06-25 /pmc/articles/PMC8437497/ /pubmed/34170788 http://dx.doi.org/10.1080/21645515.2021.1943988 Text en © 2021 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Mini-Review
He, Yang
Ding, Yi
Cao, Bo
Huang, Yi
Wang, Xiao
COVID-19 vaccine development from the perspective of cancer patients
title COVID-19 vaccine development from the perspective of cancer patients
title_full COVID-19 vaccine development from the perspective of cancer patients
title_fullStr COVID-19 vaccine development from the perspective of cancer patients
title_full_unstemmed COVID-19 vaccine development from the perspective of cancer patients
title_short COVID-19 vaccine development from the perspective of cancer patients
title_sort covid-19 vaccine development from the perspective of cancer patients
topic Mini-Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437497/
https://www.ncbi.nlm.nih.gov/pubmed/34170788
http://dx.doi.org/10.1080/21645515.2021.1943988
work_keys_str_mv AT heyang covid19vaccinedevelopmentfromtheperspectiveofcancerpatients
AT dingyi covid19vaccinedevelopmentfromtheperspectiveofcancerpatients
AT caobo covid19vaccinedevelopmentfromtheperspectiveofcancerpatients
AT huangyi covid19vaccinedevelopmentfromtheperspectiveofcancerpatients
AT wangxiao covid19vaccinedevelopmentfromtheperspectiveofcancerpatients

Ejemplares similares